DrugPatentWatch Database Preview

Details for Patent: 8,685,957

« Back to Dashboard

Which drugs does patent 8,685,957 protect, and when does it expire?

Patent 8,685,957 protects ZERBAXA and is included in one NDA.

Summary for Patent: 8,685,957

Title:	Tazobactam arginine compositions
Abstract:	This disclosure provides compositions containing solid forms of tazobactam arginine, and methods of manufacturing and using these compositions.
Inventor(s):	Lai; Jan-Ji (Westborough, MA), Gu; Jian-Qiao (Lexington, MA), Pathare; Pradip M. (Lexington, MA), Jurkauskas; Valdas (Cambridge, MA), Terracciano; Joseph (Concord, MA), Damour; Nicole Miller (Belmost, MA)
Assignee:	Cubist Pharmaceuticals, Inc. (Lexington, MA)
Application Number:	13/828,534
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 8,685,957

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Cubist Pharms Llc	ZERBAXA	ceftolozane sulfate; tazobactam sodium	POWDER;IV (INFUSION)	206829-001	Dec 19, 2014		RX	Yes	Yes				Y		METHODS OF TREATING BACTERIAL ILLNESSES

Non-Orange Book US Patents Family Members for Patent 8,685,957

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,476,425	Tazobactam arginine compositions